{"schema_version":"secwatch.filing_event.v1","accession":"0001295947-23-000014","form_type":"8-K","ticker":"PBH","cik":"0001295947","company_name":"Prestige Consumer Healthcare Inc.","filed_at":"2023-05-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.303419+00:00","generated_at":"2026-06-15T20:57:06.609979+00:00","sec_items":["2.02","7.01","8.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Prestige Consumer Healthcare reports record FY23 revenue $1.1277B; guides FY24 EPS $4.27-$4.32","bullets":["Q4 revenue $285.9M (+7.1% YoY, +8.0% organic); adjusted EPS $1.07 vs $0.91 prior year.","Full year FY23 revenue $1.1277B (record); net loss $82.3M on impairments; adjusted EPS $4.21.","FY24 guidance: revenue $1.135-$1.140B, diluted EPS $4.27-$4.32, free cash flow $240M+.","Board authorized $25M share repurchase through May 2024.","Covenant leverage ratio 3.3x; new long-term target below 3.0x."],"urls":{"canonical":"https://secwatch.observer/filing/0001295947-23-000014","json":"https://secwatch.observer/filing/0001295947-23-000014.json","markdown":"https://secwatch.observer/filing/0001295947-23-000014.md","text":"https://secwatch.observer/filing/0001295947-23-000014.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1295947/000129594723000014/0001295947-23-000014-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1295947/000129594723000014/pbh-20230504.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T20:57:06.609979+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"43705b343a1c0bf45cb48ce66d337e26b7254cf6","claim":"Prestige Consumer Healthcare Inc. reported the fiscal year ended March 31, 2023 results: revenue $1,127.7 million, net income net loss of $82.3 million, EPS diluted loss per share of $1.65.","evidence_excerpt":"Reported revenues for the fiscal year 2023 totaled $1,127.7 million, an increase of 3.8%, compared to revenues of $1,086.8 million for the fiscal year 2022.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1295947/000129594723000014/0001295947-23-000014-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fiscal year ended March 31, 2023"},{"label":"Revenue","value":"$1,127.7 million"},{"label":"Net income","value":"net loss of $82.3 million"},{"label":"EPS","value":"diluted loss per share of $1.65"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"7dfd953307014a63410f2f6b11d4f84880463857","claim":"Prestige Consumer Healthcare Inc. reported Fiscal 2024 results: revenue $1,135 to $1,140 Million, EPS $4.27 to $4.32. Guidance initiated.","evidence_excerpt":"Initial Full-Year Fiscal 2024 Revenue and EPS Expectation of $1,135 to $1,140 Million and $4.27 to $4.32, respectively","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1295947/000129594723000014/0001295947-23-000014-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"Fiscal 2024"},{"label":"Revenue","value":"$1,135 to $1,140 Million"},{"label":"EPS","value":"$4.27 to $4.32"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"},{"claim_id":"d7778f5a582d43f47f6195733ac4c4edc5129aa5","claim":"Prestige Consumer Healthcare Inc. reported the fourth quarter ended March 31, 2023 results: revenue $285.9 million, net income net loss of $240.6 million, EPS diluted loss per share of $4.83.","evidence_excerpt":"Reported revenues in the fourth quarter of fiscal 2023 of $285.9 million increased 7.1% from $266.9 million in the fourth quarter of fiscal 2022.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1295947/000129594723000014/0001295947-23-000014-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter ended March 31, 2023"},{"label":"Revenue","value":"$285.9 million"},{"label":"Net income","value":"net loss of $240.6 million"},{"label":"EPS","value":"diluted loss per share of $4.83"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}